1. About.com
  2. Health
  3. AIDS / HIV

Atripla (efavirenz + emtricitabine + tenofovir)

From , former About.com Guide

Updated November 29, 2008

About.com Health's Disease and Condition content is reviewed by the Medical Review Board

Atripla (efavirenz + emtricitabine + tenofovir)

Atripla Tablets

Photo © Gold Standard
Classification:
A combination drug consisting of a non-nucleoside reverse transcriptase inhibitor (efavirenz) and two nucleoside analog reverse transciptase inhibitors (emtricitabine and tenofovir).

Form:
A tablet consisting of 600mg of efavirenz, 200mg of emtricitabine, and 300mg of tenofovir.

Dosage:
Take one tablet once daily

Instructions:
Atripla should be taken on an empty stomach at bedtime (to avoid the side effects associated with the efavirenz).

Side Effects To Report To Your Doctor:
The side effects are those of the three individual drugs contained in Atripla. They include:
  • vivid dreams
  • restlessness or anxiety
  • drowsiness
  • dizziness
  • insomnia
  • headache
  • nausea/vomiting/diarrhea
  • loss of appetite

Important Note: About 5% of patients taking efavirenz experience severe psychiatric side effects. If you experience severe or worsening depression or other psychatric symptoms, contact your doctor immediately.

Drug Interactions:
Atripla has potential drug interactions with the following drugs:
  • drugs to treat tuberculosis
  • erectile dysfunction drugs such as Viagra or Cialis
  • antiarrythmics (heart medicine)
  • antihistamines
  • methadone (can lower methadone levels)
  • buprenorphrine (can lower buprenorphrine)
  • St. John's Wort (can lower levels of Atripla)

Special Warning:
If you intend on becoming pregnant, think you are pregnant or have had a positive pregnancy test, contact your doctor immediately. Efavirenz should not be taken while pregnant.

For More Information:
To learn more about Atripla, try About.com's Drug Finder.

More medication fact sheets

Source: Fact Sheet Number 439; AIDS Infonet, 2006.

©2012 About.com. All rights reserved. 

A part of The New York Times Company.

We comply with the HONcode standard
for trustworthy health
information: verify here.